BlackRock Launches GENIUS Act-Aligned Fund To Support Stablecoin Reserve Demand
Asset management titan BlackRock is launching a regulatory-compliant fund to support stablecoin reserve demand.
BlackRock, which has over $10 trillion in assets under its management, says it’s introducing a money market fund aligned with the GENIUS Act as a means of meeting the growing demand of the stablecoin market.
The firm says its new BlackRock Select Treasury Based Liquidity Fund (BSTBL) has a goal of increasing liquidity for its clients while being within the framework of the US Genius Act, which passed earlier this year and created clear regulatory guidelines for stablecoins.
As stated by Jon Steel, BlackRock’s global head of product and platform within its cash management business,
“We’re seeing increasing demand from stablecoin issuers and clients seeking innovative, compliant reserve management solutions. Our BSTBL money market fund builds on our history of innovation through products and marks an exciting new chapter for our cash management business.
We’re thrilled to deliver a fund that meets the evolving needs of our clients and we believe it positions BlackRock as one of the reserve asset managers of choice for the digital payments ecosystem.”
Last month, data from the crypto analytics platform Arkham revealed that BlackRock purchased $1 billion worth of Bitcoin ( BTC ), the top crypto asset by my market cap, in just one week, signaling that institutional interest in digital assets is ramping up.
BTC is trading for $106,612 at time of writing, a 1.8% decrease during the last 24 hours.
Check Price Action
Surf The Daily Hodl Mix
Featured Image: Shutterstock/mim.girl/Fotomay
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ethereum Updates Today: MoonBull’s Unique Ethereum Foundation Distinguishes It in the Competitive Meme Coin Space
- MoonBull ($MOBU) surges in Stage 6 presale with 7,244% ROI potential, leveraging Ethereum's security and deflationary tokenomics. - A structured referral system offers 15% extra tokens and USDC bonuses, driving $600K+ raised and 2,000+ holders. - Unlike meme coins, MoonBull's Ethereum-based model with staking and governance aims for sustainability, contrasting with volatile alternatives like TRUMP and XRP . - Analysts caution about crypto volatility, emphasizing ROI projections depend on market condition

From Pharmaceuticals to Blockchain: Lite Strategy's $100 Million LTC Reserve Disrupts Traditional Finance
- Lite Strategy (LITS) becomes first U.S. publicly traded company to adopt Litecoin as primary reserve asset after $100M private placement. - Partnership with crypto firm GSR and Litecoin creator Charlie Lee on board aims to institutionalize digital treasury management amid volatile markets. - $12.21M working capital and 12.39 current ratio highlight liquidity strength despite 18% YTD stock decline and mixed institutional investor reactions. - Strategic shift from pharmaceuticals to crypto reserves challen

Malaysia’s Broad Trade Approach Counters Trump Tariffs, Fuels 5.2% Economic Expansion
- Malaysia navigated Trump's 2025 tariffs via trade diversification and diplomacy, avoiding panic amid global market shocks. - U.S. reduced tariffs to 19% in October 2025 after Malaysia opened markets, coinciding with 5.2% Q3 GDP growth driven by exports and fiscal discipline. - Strategic trade ties with China, Singapore, and U.S. mitigated protectionist impacts, supported by ASEAN coordination and non-retaliatory policies. - Malaysia's $250M investment in semiconductor design and renewable energy reflects
Lite Strategy’s Balancing Game in Crypto-Pharma: Is It Possible to Manage Instability and Tradition Together?
- Lite Strategy (LITS) rebranded from MEI Pharma to focus on Litecoin , acquiring 929,548 LTC via a $100M PIPE in July 2025. - The company partners with GSR for crypto treasury management and launched a $25M share repurchase program in October 2025. - LITS holds $12.21M in working capital with no debt, while balancing pharmaceutical asset sales (e.g., ME-344) with crypto investments. - Despite strong liquidity (current ratio 12.39), the stock faces volatility risks and regulatory uncertainties in its crypt
